ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 475 filers reported holding ASTRAZENECA PLC in Q2 2017. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $391,282 | -4.5% | 5,778 | +0.9% | 0.02% | 0.0% |
| Q2 2023 | $409,933 | -0.1% | 5,728 | -3.1% | 0.02% | -11.8% |
| Q1 2023 | $410,436 | -14.4% | 5,913 | -16.4% | 0.02% | -15.0% |
| Q4 2022 | $479,393 | +24.8% | 7,071 | +0.9% | 0.02% | 0.0% |
| Q3 2022 | $384,000 | +16.4% | 7,010 | +40.6% | 0.02% | +17.6% |
| Q2 2022 | $330,000 | +0.6% | 4,987 | +1.0% | 0.02% | 0.0% |
| Q1 2022 | $328,000 | +15.1% | 4,938 | +0.8% | 0.02% | +30.8% |
| Q4 2021 | $285,000 | -3.1% | 4,899 | -0.0% | 0.01% | 0.0% |
| Q3 2021 | $294,000 | +1.4% | 4,901 | +1.3% | 0.01% | 0.0% |
| Q2 2021 | $290,000 | -14.7% | 4,839 | -29.2% | 0.01% | -18.8% |
| Q1 2021 | $340,000 | +16.8% | 6,839 | +17.5% | 0.02% | +6.7% |
| Q4 2020 | $291,000 | +10.2% | 5,819 | +20.8% | 0.02% | -11.8% |
| Q3 2020 | $264,000 | +3.5% | 4,819 | -0.0% | 0.02% | -5.6% |
| Q2 2020 | $255,000 | +18.1% | 4,820 | -0.5% | 0.02% | -10.0% |
| Q1 2020 | $216,000 | -25.8% | 4,844 | -17.0% | 0.02% | +5.3% |
| Q4 2019 | $291,000 | +11.1% | 5,837 | -0.8% | 0.02% | 0.0% |
| Q3 2019 | $262,000 | -5.1% | 5,883 | -11.8% | 0.02% | -9.5% |
| Q2 2019 | $276,000 | 0.0% | 6,668 | -2.1% | 0.02% | -4.5% |
| Q1 2019 | $276,000 | +0.7% | 6,813 | -5.5% | 0.02% | -18.5% |
| Q4 2018 | $274,000 | -17.2% | 7,209 | -14.0% | 0.03% | 0.0% |
| Q3 2018 | $331,000 | +7.8% | 8,379 | -4.0% | 0.03% | 0.0% |
| Q2 2018 | $307,000 | -19.2% | 8,729 | -19.5% | 0.03% | -27.0% |
| Q1 2018 | $380,000 | +23.8% | 10,849 | +22.6% | 0.04% | +23.3% |
| Q4 2017 | $307,000 | +2.3% | 8,848 | 0.0% | 0.03% | -6.2% |
| Q3 2017 | $300,000 | +1.4% | 8,848 | +2.0% | 0.03% | -3.0% |
| Q2 2017 | $296,000 | -0.3% | 8,677 | -9.0% | 0.03% | 0.0% |
| Q1 2017 | $297,000 | +14.2% | 9,530 | 0.0% | 0.03% | +10.0% |
| Q4 2016 | $260,000 | -18.0% | 9,530 | -1.3% | 0.03% | -28.6% |
| Q3 2016 | $317,000 | +7.1% | 9,657 | -1.5% | 0.04% | +5.0% |
| Q2 2016 | $296,000 | +3.1% | 9,807 | -3.5% | 0.04% | +8.1% |
| Q1 2016 | $287,000 | -29.0% | 10,167 | -14.5% | 0.04% | -32.7% |
| Q4 2015 | $404,000 | +22.4% | 11,897 | +14.7% | 0.06% | +31.0% |
| Q3 2015 | $330,000 | -12.5% | 10,369 | +75.5% | 0.04% | -20.8% |
| Q2 2015 | $377,000 | -25.6% | 5,908 | -20.2% | 0.05% | -56.6% |
| Q1 2015 | $507,000 | -19.5% | 7,407 | -17.2% | 0.12% | -25.2% |
| Q4 2014 | $630,000 | -4.0% | 8,948 | -2.5% | 0.16% | -5.2% |
| Q3 2014 | $656,000 | -19.7% | 9,178 | -16.5% | 0.17% | -19.6% |
| Q2 2014 | $817,000 | +5.4% | 10,994 | -7.9% | 0.21% | -1.8% |
| Q1 2014 | $775,000 | -88.5% | 11,939 | -89.4% | 0.22% | -89.1% |
| Q4 2013 | $6,716,000 | +19.2% | 113,112 | +4.3% | 2.01% | +5.4% |
| Q3 2013 | $5,632,000 | +18.0% | 108,441 | +7.5% | 1.90% | +9.5% |
| Q2 2013 | $4,772,000 | – | 100,871 | – | 1.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |